Special Issue

Topic: Drug Resistance and Cancer Stem Cell
Guest Editor(s)
Special Issue Introduction
Solid tumors as well as leukemias and lymphomas depend for their proliferation on a small group of progenitor cells, the cancer stem cells. These are tumorigenic and both self-renew and generate more differentiated, non-tumorigenic cells. The cancer stem cells are responsible for metastases, as well as for the post-therapeutic relapses of tumors. Therefore, there is a great interest and importance in identifying and, if possible, specifically targeting the cancer stem cells. Recent developments in single cell omics approaches hold great promise in this regard.
The Special Issue on "Cancer Stem Cells" will include Original Articles, Reviews, Commentaries, etc. updating the current state of knowledge and clinical uses of identifying and targeting cancer stem cells. The Special Issue will also include Research articles presenting novel outstanding data on all aspects of cancer stem cell-targeted therapies. All submissions will undergo rigorous peer review and will be published free of charge upon acceptance.
The Special Issue on "Cancer Stem Cells" will include Original Articles, Reviews, Commentaries, etc. updating the current state of knowledge and clinical uses of identifying and targeting cancer stem cells. The Special Issue will also include Research articles presenting novel outstanding data on all aspects of cancer stem cell-targeted therapies. All submissions will undergo rigorous peer review and will be published free of charge upon acceptance.
Keywords
Biomarkers, differentiation therapy, metastasis, omics, relapse, single cell studies, stemness
Submission Deadline
31 Aug 2019
Submission Information
For Author Instructions, please refer to https://oaepublish.com/cdr/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=cdr&SpecialIssueId=245
Submission Deadline: 31 Aug 2019
Contacts: Elaine Gao, Managing Editor, editorial@cdrjournal.com
Chloe Yang, Assistant Editor, chloe@cdrjournal.com
Published Articles
Open Access Review
How to conjugate the stemness marker ALDH1A1 with tumor angiogenesis, progression, and drug resistance
This article belongs to the Special Issue Drug Resistance and Cancer Stem Cell
Cancer Drug Resist 2020;3:26-37.
DOI: 10.20517/cdr.2019.70
Available online: 18 Mar 2020
Open Access Original Article
Gene silencing of HIF-2α disrupts glioblastoma stem cell phenotype
This article belongs to the Special Issue Drug Resistance and Cancer Stem Cell
Cancer Drug Resist 2020;3:199-208.
DOI: 10.20517/cdr.2019.96
Available online: 10 Mar 2020
Open Access Review
Cancer stem cells, plasticity, and drug resistance
This article belongs to the Special Issue Drug Resistance and Cancer Stem Cell
Cancer Drug Resist 2020;3:140-8.
Available online: 20 Feb 2020
Open Access Review
Relationship between ovarian cancer stem cells, epithelial mesenchymal transition and tumour recurrence
This article belongs to the Special Issue Drug Resistance and Cancer Stem Cell
Cancer Drug Resist 2019;2:1127-35.
DOI: 10.20517/cdr.2019.76
Available online: 18 Dec 2019
Open Access Review
Cancer stem cells in neuroblastoma therapy resistance
This article belongs to the Special Issue Drug Resistance and Cancer Stem Cell
Cancer Drug Resist 2019;2:948-67.
DOI: 10.20517/cdr.2019.72
Available online: 18 Dec 2019
Open Access Review
Colorectal cancer stem cells properties and features: evidence of interleukin-8 involvement
This article belongs to the Special Issue Drug Resistance and Cancer Stem Cell
Cancer Drug Resist 2019;2:968-79.
DOI: 10.20517/cdr.2019.56
Available online: 18 Dec 2019
Open Access Review
Computational analyses for cancer biology based on exhaustive experimental backgrounds
This article belongs to the Special Issue Drug Resistance and Cancer Stem Cell
Cancer Drug Resist 2019;2:419-27.
DOI: 10.20517/cdr.2019.33
Available online: 18 Sep 2019
Open Access Review
Drug resistance mechanisms of cancer stem-like cells and their therapeutic potential as drug targets
This article belongs to the Special Issue Drug Resistance and Cancer Stem Cell
Cancer Drug Resist 2019;2:457-70.
DOI: 10.20517/cdr.2019.36
Available online: 18 Sep 2019